Perceptive Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Sell |
|
|||||
|
2025
Q1 | $41.4M | Sell |
|
|||||
|
2024
Q4 | $56.2M | Sell |
|
|||||
|
2024
Q3 | $70.4M | Buy |
|
|||||
|
2024
Q2 | $37M | Sell |
|
|||||
|
2024
Q1 | $88.2M | Buy |
|
|||||
|
2023
Q4 | $82.6M | Buy |
|
|||||
|
2023
Q3 | $33.7M | Buy |
|
|||||
|
2023
Q2 | $19.5M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $3.04M | Hold |
|
|||||
|
2021
Q3 | $2.65M | Sell |
|
|||||
|
2021
Q2 | $37.4M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $4.11M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.09M | Hold |
|
|||||
|
2019
Q2 | $1.39M | Hold |
|
|||||
|
2019
Q1 | $767K | Buy |
|